Acumen Pharmaceuticals
Price & Volume
Stats
See moreOpen | $0.98 |
Previous Close | $1.02 |
Day Range | $0.98-$1.12 |
52W Range | $0.90-$3.92 |
Market Cap | $63.5M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $329,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$93.7M |
Diluted EPS | -$1.66 |
News
See moreYahoo Finance • 9 days ago
Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
Yahoo Finance • 24 days ago
Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer’s
Yahoo Finance • 30 days ago
Acumen Pharmaceuticals to Present During International Conference on Alzheimer’s and Parkinson’s Diseases 2025 and American Academy of Neurology Annual Meeting
Yahoo Finance • last month
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
About
CEO | Mr. Daniel J. O'Connell M.B.A. |
CFO | Mr. Matt Zuga |
Address | 1210-1220 Washington St., Newton, MA, United States, 02465 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
